Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Celonic
Basel, Basel-City, Switzerlandcelonic.com ↗
- Ownership
- Private
- Employees
- ~302
- Development stage
- Other
01
Overview
Celonic does not have its own clinical pipeline but provides end-to-end development and GMP manufacturing services for biologics—including cell line development, process optimization/scale-up/tech transfer—for biotech/pharma clients. It has integrated next-generation technologies like the Breez™ micro-bioreactor to enhance efficiency in monoclonal antibody production. No direct clinical results are reported since it operates as a CDMO rather than a product company.
- Modalities
- Monoclonal antibodyBispecific monoclonal antibodyRecombinant proteinBiologic
- Industry
- Contract Manufacturing Organization
02
Partnerships
Merck KGaA
Beyond the preview
Go deeper on Celonic.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Celonic.